Table A4.
Outcomes and Vaccine Effectiveness | Vaccine Effectiveness (95% CI): BNT162b2 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Fully Adjusted | Unadjusted | Partially Unadjusted (No Trend and State Dummies) | Partially Adjusted (No State Dummies) | Partially Adjusted (No Comorbidities Dummy) | ||||||
VE | 95% CI | VE | 95% CI | VE | 95% CI | VE | 95% CI | VE | 95% CI | |
Admission to ICU | ||||||||||
Partially vaccinated | 34.3 | 30.2, 38.1 | 25.2 | 20.8, 29.3 | 47.2 | 44.1, 50.2 | 36.4 | 32.5, 40.1 | 36.8 | 32.9, 40.4 |
Fully vaccinated | 90.3 | 88.8, 91.6 | 88.2 | 86.4, 89.8 | 93.3 | 92.3, 94.2 | 91.2 | 89.9, 92.4 | 92.1 | 90.8, 93.1 |
Confirmed death | ||||||||||
Partially vaccinated | 48.1 | 44.5, 51.4 | 14.7 | 10.3, 18.9 | 39.8 | 36.4, 43.1 | 45.1 | 41.9, 48.1 | 46.2 | 43.2, 49.0 |
Fully vaccinated | 92.7 | 91.7, 93.6 | 80.9 | 78.8, 82.8 | 91.6 | 90.6, 92.5 | 92.8 | 92.0, 93.6 | 93.5 | 92.8, 94.2 |
Abbreviations: CI, confidence intervals; COVID-19, coronavirus disease; ICU, intensive care unit; VE, vaccine effectiveness; AZD1222, Oxford-AstraZeneca; BNT162b2, Pfizer-BioNTech; CoronaVac, Sinovac.